Skip to content
Gold Mining News – Lifestyle
Author:
Jaguar Health, Inc.
Jaguar Health Provides Update Regarding Special Stock Dividend
October 14, 2026
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health’s Crofelemer
October 14, 2026
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health’s Special Stock Dividend
October 13, 2026
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
October 6, 2026
Jaguar Health Announces a Special Stock Dividend
October 2, 2026
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health’s Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
September 29, 2026
Jaguar Health Receives Fee Waivers from FDA
September 22, 2026
Jaguar Health, Inc. Announces Reverse Stock Split
September 15, 2026
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health’s Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
September 10, 2026
Neonorm Dog Now on Amazon: Jaguar Health Digestive Support
September 8, 2026
1
2
3
4
Next Page
→